Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2232 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

SuperGen’s chief medical officer leaves

Michael Young, a current member of the SuperGen board of directors and chairman and chief scientific officer of Strategic Healthcare Development, will serve as SuperGen’s interim chief medical

Alseres and BioAxone amend licensing agreement

The amendment replaces all of the pre-commercial financial and performance-related milestones contained in the Cethrin license with a formula-based approach to sharing any and all income generated under

Optherion wins two new Canadian patents

The claims of the issued patents provide secure protection for diagnostic tests for determining the predisposition to age-related macular degeneration (AMD) by screening for genetic modifications in several